The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Epidemiological Parkinson's Risk Modifiers, 2019Study in French Population to Identify Therapies with Repurposing Potential for Parkinson’s Disease
Study Rationale:
There is an urgent need to identify effective, safe and inexpensive drugs for Parkinson’s disease, and over past years, there has been increasing interest on ways to repurpose... -
Research Grant, 2019Alpha-Synuclein PET Imaging Tracer Development
Study Rationale:
Alpha-synuclein is a protein that aggregates in several brain diseases, including Parkinson’s, dementia with Lewy bodies and multiple system atrophy. There is no established method... -
Target Advancement Program, 2019Analysis and Amplification of Pathological Alpha-synuclein from Brain Tissue
Study Rationale:
Parkinson’s disease is characterized by the misfolding and accumulation of the alpha-synuclein protein in the brain. Therefore, alpha-synuclein-based disease... -
Target Advancement Program, 2019GBA Stabilization through Nanobodies
Study Rationale:
Mutations in the GBA gene are a known genetic risk factor for Parkinson’s disease and cause reduced stability and activity of the GBA protein. This can contribute to the impairment of... -
Research Grant, 2019Targeting LRRK2 in Models of Gastrointestinal Inflammation
Study Rationale:
We seek to investigate the extent to which gut inflammation triggers brain inflammation and Parkinson’s-like pathology and the role of LRRK2 and Tumor Necrosis Factor (TNF)-dependent... -
LRRK2 Biology Consortium, 2019Biochemical and Structural Characterization of LRRK2-specific Nanobodies
Study Rationale:
Malfunctioning of the protein leucine-rich repeat kinase 2 (LRRK2) is a common genetic cause of Parkinson’s disease (PD). LRRK2 is a very large and complex protein, and insight into t...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.